Literature DB >> 6737073

Disproportionate effects of regional hypokinesis on radionuclide ejection fraction: compensation using attenuation-corrected ventricular volumes.

R M Schneider, R J Jaszczak, R E Coleman, F R Cobb.   

Abstract

This study evaluates the potential effects of regional hypokinesis on measurements of global ejection fraction (EF) as determined by radionuclide angiographic techniques. Studies were performed in a two-compartment left-ventricular (LV) model that allowed stimulation of global, anterior-region, or posterior-region hypokinesis in a torso chamber with heart-to-background activity similar to that in clinical studies. Radionuclide techniques accurately measured changes in EF during global hypokinesis but progressively underestimated true EF during increasing anterior-region hypokinesis, and progressively overestimated true EF during increasing posterior hypokinesis. When EF (y-axis) was plotted against true EF (x-axis) for a 240-ml model, from linear regression equations, the slopes and intercepts were significantly different for anterior and posterior hypokinesis. The disproportionate effects of regional hypokinesis increased with LV size. Accurate EF was computed during regional hypokinesis by determining absolute LV volumes from count rates corrected for attenuation, depth, background activity and blood-pool activity. Thus, the disproportionate effects of regional hypokinesis on EF were corrected by considering differential count attenuation.

Entities:  

Mesh:

Year:  1984        PMID: 6737073

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

1.  Assessment of left ventricular function: comparison between radionuclide angiography and semiquantitative two-dimensional echocardiographic analysis.

Authors:  M Gottsauner-Wolf; J Schedlmayer-Duit; G Porenta; M Gwechenberger; K Huber; D Glogar; P Probst; H Sochor
Journal:  Eur J Nucl Med       Date:  1996-12

2.  Long term improvement in global left ventricular function after early thrombolytic treatment in acute myocardial infarction.

Authors:  A L Muir; J Nicoll
Journal:  Br Heart J       Date:  1987-07

3.  A prospective comparison of echocardiographic wall motion score index and radionuclide ejection fraction in predicting outcome following acute myocardial infarction.

Authors:  G I Galasko; S Basu; A Lahiri; R Senior
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

4.  Feasibility of first-pass radionuclide angiocardiography with a 10-mCi technetium bolus using a single-crystal digital gamma camera: implications for technetium-sestamibi single-day protocols.

Authors:  J P Esquerré; F J Coca; P Gantet; E Ouhayoun
Journal:  Eur J Nucl Med       Date:  1995-06

5.  Measurement of left ventricular ejection fraction from gated technetium-99m sestamibi myocardial images.

Authors:  S Boonyaprapa; M Ekmahachai; N Thanachaikun; W Jaiprasert; V Sukthomya; N Poramatikul
Journal:  Eur J Nucl Med       Date:  1995-06

6.  Use of radionuclide angiography and an electrocardiographic stress test to diagnose multivessel disease after a first episode of uncomplicated myocardial infarction.

Authors:  A Fubini; E Cecchi; M T Spinnler; M Di Leo; S Bergerone; F Orzan; P Presbitero; P Morello; G Castellano; G Turco
Journal:  Br Heart J       Date:  1986-06

7.  Differential sensitivity of radionuclide ventriculography for the detection of anterior and inferior infarction.

Authors:  S R Underwood; S Walton; P J Laming; P J Ell; R W Emanuel; R H Swanton
Journal:  Br Heart J       Date:  1988-11

8.  Improved assessment of inferior left ventricular wall motion using biplane equilibrium radionuclide ventriculography.

Authors:  E M Prvulovich; G M Shah Syed; S R Underwood; D E Jewitt
Journal:  Eur J Nucl Med       Date:  1994-05

9.  Is echocardiography a valid tool to screen for left ventricular systolic dysfunction in chronic survivors of acute myocardial infarction? A comparison with radionuclide ventriculography.

Authors:  G I W Galasko; S Basu; A Lahiri; R Senior
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.